Clinical Trials Browser

Interventional × von Hippel-Lindau Disease × Clear all

NCT00102544 2026-06-01

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Phase NA Enrolling by invitation

Adenocarcinoma, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Prostatic Neoplasms

NCT07405164 2026-05-29

MK-6482-043

Phase 3 Recruiting

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT04924075 2026-05-28

MK-6482-015

Phase 2 Recruiting

322 enrolled 1 FDA

von Hippel-Lindau Disease, Adenoma, Islet Cell, Paraganglioma, Pheochromocytoma

NCT07557225 2026-05-14

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Phase NA Recruiting

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, von Hippel-Lindau Disease, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT04074135 2026-04-20

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Phase 2 Recruiting

EndocrineGastrointestinalNET

von Hippel-Lindau Disease, Pancreatic Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

NCT03401788 2026-04-13

MK-6482-004

Phase 2 Active not recruiting

50 enrolled 1 FDA

von Hippel-Lindau Disease

NCT04895748 2026-03-03

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Phase 1 Terminated

CNSEndocrineGenitourinary

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Paraganglioma, Pheochromocytoma

NCT07167329 2025-09-11

BELIEVE-VHL

Phase 2 Recruiting

CNSEndocrineGenitourinary

Carcinoma, Renal Cell, von Hippel-Lindau Disease, Paraganglioma, Pheochromocytoma, Neuroectodermal Tumors, Primitive, Hemangioblastoma

NCT03108066 2024-09-24

MK-3795-003

Phase 2 Completed

4 enrolled 11 charts

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT06553339 2024-08-14

A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors

Phase 1 Recruiting

von Hippel-Lindau Disease, Neuroectodermal Tumors, Primitive

NCT00330564 2024-06-27

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Phase 2 Terminated

15 enrolled 5 charts

Carcinoma, Renal Cell, Cysts, von Hippel-Lindau Disease, Neoplasms, Hemangioblastoma

NCT05424016 2023-12-13

PRO-HEB

Phase NA Recruiting

von Hippel-Lindau Disease, Hemangioblastoma

NCT05843305 2023-05-06

A Study of BPI-452080 in Subjects With Solid Tumors

Phase 1 Unknown

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT03001349 2021-02-15

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Phase EARLY_PHASE1 Terminated

CNSEndocrineNET

von Hippel-Lindau Disease, Meningioma, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

NCT01967537 2019-11-19

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Phase 2 Completed

341 enrolled 14 charts

von Hippel-Lindau Disease, Neuroendocrine Tumors

NCT02108002 2018-09-14

Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)

Phase 1 Completed

von Hippel-Lindau Disease, Hemangioblastoma

NCT00089765 2017-07-02

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Phase 1 Completed

von Hippel-Lindau Disease, Macular Edema, Neoplasms

NCT00052013 2017-03-06

Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584

Phase 2 Completed

von Hippel-Lindau Disease, Hemangioblastoma

NCT01266070 2017-02-13

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Phase 2 Terminated

6 enrolled 5 charts

von Hippel-Lindau Disease, Central Nervous System Neoplasms, Hemangioblastoma

NCT00088374 2012-07-27

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Phase 2 Completed

9 enrolled 8 charts

Carcinoma, Renal Cell, von Hippel-Lindau Disease, Kidney Neoplasms

NCT01015300 2012-05-11

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Phase EARLY_PHASE1 Terminated

von Hippel-Lindau Disease, Hemangioblastoma

NCT00056199 2008-03-04

EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Phase 1 Completed

von Hippel-Lindau Disease, Macular Edema, Vision Disorders, Optic Nerve Neoplasms